Characterising <sup>18</sup>F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging.

A slight trend toward an increase in uptake was seen in triple-negative breast cancers compared to other hormone receptor types (not significant), as reported in a smaller study by Tade et al.

also in 4,078 other papers